Or Mahler

Envoya is at the forefront of biotechnological innovation, specializing in developing non-lipid polymer based nanoparticles for gene therapy. Dedicated to revolutionizing the gene therapy applications to treat genetic disorders effectively. Our expertise in polymer science and nanotechnology positions us as a key player in the healthcare sector. At Envoya, we are committed to pushing the boundaries of medical science. Our team of experts leverages profound knowledge and innovative techniques to create smart nanoparticles from polymers to deliver gene therapy safely and effectively. Our goal is to fix genetic disorders and improve lives with our cutting-edge technology. We focus on creating solutions that address the complexities of gene delivery with precision. Our offerings include: • Customized Delivery Solutions: Tailoring treatments to meet the specific genetic needs of patients. • Research and Development in Polymer Science: Innovating at the intersection of polymer science and genetic therapy. We believe in the power of science to change lives. We are dedicated to creating a healthier future through our innovative gene therapy delivery solutions. Contact us today to explore how our advancements in gene therapy delivery can benefit your healthcare goals. 📧info@envoyabio.com 🔗https://www.envoyabio.com/contact Do visit our website to learn more about how we are leading in science for a better future. 🌐https://www.envoyabio.com/

Zeroport is the first non-IP secure remote access solution provider. Using a patented physical bridge deployed at the gateway of an organization’s network, Zeroport enables only human interactions in and only a stream of pixels out - so no packet (no digital signal) enters or exits the network, all while enabling latency-free work at linear scale. This approach solves the biggest network access pains for both isolated and connected networks - it brings air-gapped networks from 0 to 1 in their remote access journey by enabling secure connectivity from remote locations while keeping their air-gap intact. For connected organizations relying on traditional remote access stacks, Zeroport helps modernize and simplify their cumbersome, costly and vulnerable remote access approach, currently plagued with extreme vendor fatigue and security-patch chaos. With offices in New York, Israel and Singapore, Zeroport serves financial institutions, critical infrastructure, industrial enterprises, and public-sector organizations worldwide.

Envoya is at the forefront of biotechnological innovation, specializing in developing non-lipid polymer based nanoparticles for gene therapy. Dedicated to revolutionizing the gene therapy applications to treat genetic disorders effectively. Our expertise in polymer science and nanotechnology positions us as a key player in the healthcare sector. At Envoya, we are committed to pushing the boundaries of medical science. Our team of experts leverages profound knowledge and innovative techniques to create smart nanoparticles from polymers to deliver gene therapy safely and effectively. Our goal is to fix genetic disorders and improve lives with our cutting-edge technology. We focus on creating solutions that address the complexities of gene delivery with precision. Our offerings include: • Customized Delivery Solutions: Tailoring treatments to meet the specific genetic needs of patients. • Research and Development in Polymer Science: Innovating at the intersection of polymer science and genetic therapy. We believe in the power of science to change lives. We are dedicated to creating a healthier future through our innovative gene therapy delivery solutions. Contact us today to explore how our advancements in gene therapy delivery can benefit your healthcare goals. 📧info@envoyabio.com 🔗https://www.envoyabio.com/contact Do visit our website to learn more about how we are leading in science for a better future. 🌐https://www.envoyabio.com/

Zeroport is the first non-IP secure remote access solution provider. Using a patented physical bridge deployed at the gateway of an organization’s network, Zeroport enables only human interactions in and only a stream of pixels out - so no packet (no digital signal) enters or exits the network, all while enabling latency-free work at linear scale. This approach solves the biggest network access pains for both isolated and connected networks - it brings air-gapped networks from 0 to 1 in their remote access journey by enabling secure connectivity from remote locations while keeping their air-gap intact. For connected organizations relying on traditional remote access stacks, Zeroport helps modernize and simplify their cumbersome, costly and vulnerable remote access approach, currently plagued with extreme vendor fatigue and security-patch chaos. With offices in New York, Israel and Singapore, Zeroport serves financial institutions, critical infrastructure, industrial enterprises, and public-sector organizations worldwide.